期刊文献+

新辅助化疗治疗宫颈癌对细胞增殖与凋亡的影响分析 被引量:2

Effects Analysis of Neoadjuvant Chemotherapy in Treatment of Cervical Cancer Cell Proliferation and Apoptosis
原文传递
导出
摘要 目的探讨新辅助化疗治疗宫颈癌对细胞增殖与凋亡的影响,从而了解新辅助动脉化疗的作用机制,为宫颈癌的治疗提供参考。方法 52例Ib-IIb期宫颈癌患者平分两组,观察组施行动脉灌注栓塞化疗后手术,对照组直接手术治疗,观察临床疗效。分别记录两组手术病例的术中出血量,并作比较;同时检测动脉灌注栓塞化疗前、后及直接手术患者的肿瘤细胞增殖指数(Ki-67)及凋亡指数(AI)。结果观察组宫颈癌动脉灌注栓塞化疗总有效率为80.8%,对照组术后须行放疗或化疗者20例,占76.9%。观察组手术病例手术出血量为(362.5±11.5)ml,对照组手术出血量为(524.5±15.0)ml,两组比较差异有统计学意义(P<0.05)。观察组动脉化疗前活检标本,Ki-67指数(%)为(67.5±76),对照组直接手术病理标本,Ki-67指数(%)为(80.1±8.5)。观察组AI(%)为(3.5±1.3),对照组检测AI(%)为(0.8±0.3)。结论 Ib-IIb期宫颈癌行新辅助动脉灌注栓塞化疗,可显著缩小病灶体积,从而提高患者生活质量。可明显减少手术中出血量,有利于患者康复。同时促进肿瘤细胞增殖显著下降、凋亡显著增加,提示动脉化疗有抑制肿瘤细胞增殖、促进凋亡的作用。 Objective To discuss the effects of neoadjuvant chemotherapy in treatment of cervical cancer cell proliferation and apoptosis for understanding the role of neoadjuvant intraarterial chemotherapy mechanism and provide a reference for the treatment of cervical cancer. Methods Totally 52 cases of Ib-IIb cervical cancer patients were divided into two groups,the observation group were impleted the arterial chemoembolization after operation,the control group were directly treated by the surgical treatment,the clinical efficacy was observed.And the haemorrhage volume during opertation of the two groups were recorded;Simultaneously detected the tumor cell proliferation index(Ki-67) and apoptosis index(AI) of arterial embolization chemotherapy before and directly after surgery in patients. Results The total effective rate of the observation group was 80.8%,and 20 cases were treated by the radiotherapy or chemotherapy after surgery in the control group.The observation group of the patients with haemorrhage volume was(362.5±11.5)ml,so that was(524.5±15.0)ml in the control group(P0.05).The Ki-67 index(%) was(67.5±76) of artery biopsy specimens before chemotherapy in the observation group,so that was(80.1±8.5) in the control group.The AI(%) was(3.5±1.3) in the observation group,so that was(0.8±0.3) in the control group. Conclusion Neoadjuvant chemotherapy in treatment of cervical cancer can significantly reduce the tumor volume,enhance the quality of life.So it can significantly reduce the amount of bleeding,it is good for patients to rehabilitation.Also it can promote tumor cell proliferation and apoptosis,this suggests that arterial chemotherapy can inhibit tumor cell proliferation and apoptosis.
作者 郁胜 吴平
出处 《医药论坛杂志》 2010年第24期29-32,共4页 Journal of Medical Forum
关键词 宫颈癌 动脉灌注栓塞化疗 细胞增殖 细胞凋亡 Cervical cancer Arterial chemoembolization Cell proliferation Cell apoptosis
  • 相关文献

参考文献10

  • 1Juan E Sardi, Mafia A Boixadera, Juan J Sardi. Neoadjuvant Chemotherapy in Cervical Cancer: A New Trend [ J ]. Current Opinion in Obstetrics and Gynecology, 2005,17:43-47.
  • 2Kuzuya K. Chemoradiotherapy for uterine cancer: status and perspectives [ J ]. International Journal of Clinical Oncology,2004,9(6) :458-470.
  • 3Ikeda N Mizukami Y, Murata, et al. Randomized Compari- son for Intraarterial Chemotherapy Versus Intra - Arterial Chemotherapy and Gelfoam Embolization for Treatment of Advanced Cervical Carcinoma [ J ]. Cardio Vascular and lmerventional Radiology ,2005,28:736-743.
  • 4Sarian L 0, Derchain S F, Yoshida A, et al. Expression of cyclo - oxygenase - 2 ( COX . 2 ) and Ki - 67 as related to disease severity and HPV detection in squamous lesions of- the cervix [ J ]. Gynecol Onco1,2006,102 ( 3 ) :537-541.
  • 5Sahebali S, Depuydi C E, Segers K, et al. Ki67 immunocylo - chemistry in liquid based cervical cylology : Useful as an adjunctive [ J ]. J C lni Pathol, 2003,56 ( 9 ) : 681- 686.
  • 6Carriho C. Gouveia P. Cante M, et al. characterization of human papilomavirus infection,p53 and Ki- 67 expression in cervix cancer of Mozambican women [J].Pathlo Res Pract, 2003,199 ( 5 ) : 303-311.
  • 7Antonella Savarese, Francesco Cognetti. New drugs in the treatment of recurrent or metastatic cervical cancer [J]. Critical Reviews on Oncology Pdematology,2003, 48 (30) : 323-327.
  • 8刘凌,程惠敏.宫颈鳞癌放疗前后病理组织学、细胞凋亡、增殖细胞核抗原及p53的变化[J].徐州医学院学报,2008,28(3):148-150. 被引量:5
  • 9钱晓蕾,彭芝兰,胡敏,牛晓宇,陈悦悦.顺铂与卡铂对宫颈癌化疗作用的对照研究[J].现代预防医学,2006,33(7):1131-1132. 被引量:8
  • 10刘萍,陈春林,曾北蓝,马奔,张浩.宫颈癌术前动脉化疗的组织病理学动态变化及临床结局[J].中国实用妇科与产科杂志,2006,22(2):109-111. 被引量:52

二级参考文献16

  • 1沈铿.卵巢癌化学治疗的发展和挑战[J].中国妇产科临床杂志,2002,3(1):3-7. 被引量:9
  • 2李方.细胞凋谢与肿瘤[J].国外医学(肿瘤学分册),1994,21(4):193-196. 被引量:4
  • 3陈春林,谭道彩,梁立治.动、静脉灌注化疗子宫颈癌组织药物浓度的比较[J].中华妇产科杂志,1995,30(5):298-298. 被引量:172
  • 4张弘纲,王奇璐,王宏羽,王子平,谢雅莉.卡铂Ⅲ期临床试用结果(附419例恶性肿瘤疗效分析)[J].实用肿瘤杂志,1996,11(2):66-69. 被引量:14
  • 5Strecker EP,Heber R,Boos I,et al.Preliminary experience with locoregional intraarterial chemotherapy of uterine cervical or endometrial cancer using the peripheral implantable port system (PIPS):a feasibility study[J].Cardiovasc Intervent Radiol,2003,26(2):118-120.
  • 6Kobayashi K,Furukawa A,Takahashi M,et al.Neoadjuvant intra-arterial chemotherapy for locally advanced uterine cervical cancer:clinical efficacy and factors influencing response[J].Cardiovasc Intervent Radiol,2003,26(3):234-241.
  • 7Sevin BU,Peng ZL,Perras JP,Ganjei P,Penalver M,Averette HE.Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing[J].Gynecol Oncol,1988,31:191-204.
  • 8NguYen HN,Sevin BU,Averette HE,Perras J,Donato D,Penalver M.Comparative evaluation of single and combination chemotherapy in uterine cancer cell lines[J].Gynecol Oncol,1991; 42:227-232.
  • 9Higgins RV,Naumann WR,Hall JB,Haake M.Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer[J].Gynecol Oncol.2003,89 (3):499-503.
  • 10Stephens LC, Schultheiss TE, Small SM, et al. Response of parotid gland organ culture to radiation [ J]. Radiat Res, 1989,120 (1) :140 -153.

共引文献62

同被引文献41

  • 1谢多玲,庞苗.局部晚期宫颈癌的不同新辅助化疗方案疗效观察[J].实用医技杂志,2008,15(17):2259-2260. 被引量:1
  • 2Ye Q,Yuan HX, Chen HL. Responsiveness of neoadjuvant chemother- apy before surgery predicts favorable prognosis for cervical cancer pa- tients : a meta-analysis [ J ]. Journal of cancer research and clinical on- cology,2013,139 ( 11 ) : 1887 -1898.
  • 3Kamura T, Ushijima K. Chemotherapy for advanced or recurrent cervi- cal cancer[ J]. Taiwan Residents Journal of Obstetrics and Gynecology,2013, 52(2) :161-164.
  • 4Mabuchi S, Morishige K, Fujita M, et al. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy [ J ]. Gynecologic Oncology,2009,1 13 ( 2 ) : 200-204.
  • 5Chen H, Liang C, Zhang L, et al. Clinical efficacy of modified preoper- ative neoadjuvant chemotherapy in the treatment of locally advanced (stage I B2 to il B)cervical cancer: randomized study [ J ]. Gynecol Oncol, 2008,110 ( 3 ) : 308-315.
  • 6Takekida S,Fujiwara K,Nagao S,et al. Phase lI study of combina- tion chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer [ J ]. Int J Gynecol Cancer, 2010,20 ( 9 ) : 1563 -1568.
  • 7Mossa B, Mossa S ; Corosu L, et al. Follow-up in a long-term random- ized trim with neoadjuvant chemotherapy for squamous cell cervical carcinoma[ J ]. European journal of gynaecological oncology,2010,31 (5) :497-503.
  • 8Katsumata N, Yoshikawa H, Kobayashi H, et al. Phase II randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer:a Japan Clinical Oncology Group trial( JCOG 0102 ) [ J]. British journalof cancer,2013,108 (10) : 1957-1963.
  • 9Ki KD, Song DH, Tong SY,et al. Neoadjuvant chemotherapy in bulky stage IB-IIA cervical cancer:results of a quick course with vineris- tine, bleomycin, and cisplatin[J]. International Journal of Gynecolog- ical Cancer,2009,19( 1 ) :50-53.
  • 10Rydzewska L, Tierney J, Vale CL, et al. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer [J]. Cochrane Data- base Syst Rev,2010( 1 ) :CD007406.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部